SEOUL, South Korea, Nov. 2, 2005 (PRIMEZONE) -- Meridian Co., Ltd. (Meridian) (OTCBB:MRDAF) today announced that Meridian Medical Inc. (MMI), Meridian's North American sales and distribution office, will be attending the American College for Advancement in Medicine (ACAM).
Attending conferences, such as the 64th International Conference established by the American College for Advancement in Medicine(ACAM), is significant for Meridian Co., Ltd. due to the large number of potential interested parties and customers also in attendance. The ACAM conference will permit the company to showcase its products in person to potential sales candidates thereby dramatically reducing the duration of the sales cycle in terms of completing transactions.
This is the second year that MMI has attended the conference.
ACAM is a not-for-profit medical society dedicated to educating physicians and other health care professionals on the latest findings and emerging procedures in preventive/nutritional medicine. ACAM's goals are to improve skills, knowledge and diagnostic procedures as they relate to complementary and alternative medicine; to support research; and to develop awareness of alternative methods of medical treatment.
Celebrating more than a quarter century of service, ACAM represents more than 1,000 physicians in 30 countries. ACAM is the largest and oldest organization of its kind in the world dedicated exclusively to serving the educational needs of the health professions.
ACAM's mission is to:
1. Educate physicians, students and other healthcare practitioners.
2. Influence healthcare policy and education.
3. Advance clinical research.
4. Foster cohesive relationships among colleagues.
5. Be the preferred source of knowledge and information in
complimentary, integrative and alternative medicine.
About Meridian
Meridian is an established leader in the research/development, manufacturing and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.
On Behalf of the Board of Directors,
Hyeon Seong Myeong President
This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the company.
HTML: http://newsroom.eworldwire.com/wr/110205/13026.htm PDF: http://newsroom.eworldwire.com/pdf/110205/13026.pdf ONLINE NEWSROOM: http://newsroom.eworldwire.com/307280.htm NEWSROOM RSS FEED: http://newsroom.eworldwire.com/xml/newsrooms/307280.xml LOGO: http://newsroom.eworldwire.com/307280.htm